Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:23 pm Purchase |
2024-12-31 | 13G | VolitionRx Limited VNRX |
Armistice Capital, LLC | 9,343,265 9.990% |
119,885 (+1.30%) |
Filing History |
| 2025-02-14 5:22 pm Purchase |
2024-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Armistice Capital, LLC | 4,475,121 9.990% |
4,475,121 (New Position) |
Filing History |
| 2025-02-14 5:22 pm Sale |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Armistice Capital, LLC | 7,358,000 9.620% |
-290,000 (-3.79%) |
Filing History |
| 2025-02-14 5:21 pm Purchase |
2024-12-31 | 13G | Treace Medical Concepts, Inc. TMCI |
Armistice Capital, LLC | 6,209,000 9.970% |
13,000 (+0.21%) |
Filing History |
| 2025-02-14 5:21 pm Purchase |
2024-12-31 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP |
Armistice Capital, LLC | 95,373 9.990% |
56,121 (+142.97%) |
Filing History |
| 2025-02-14 5:20 pm Sale |
2024-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
Armistice Capital, LLC | 4,836,000 8.760% |
-260,000 (-5.10%) |
Filing History |
| 2025-02-14 5:20 pm Purchase |
2024-12-31 | 13G | Steakholder Foods Ltd. STKH |
Armistice Capital, LLC | 346,487 9.990% |
19,594 (+5.99%) |
Filing History |
| 2025-02-14 5:19 pm Unchanged |
2024-12-31 | 13G | Sadot Group Inc. SDOT |
Armistice Capital, LLC | 411,523 6.560% |
0 (Unchanged) |
Filing History |
| 2025-02-14 5:19 pm Sale |
2024-12-31 | 13G | Rockwell Medical, Inc. RMTI |
Armistice Capital, LLC | 3,249,178 9.990% |
-332,347 (-9.28%) |
Filing History |
| 2025-02-14 5:18 pm Sale |
2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Armistice Capital, LLC | 1,152,000 6.540% |
-384,000 (-25.00%) |
Filing History |
| 2025-02-14 5:18 pm Sale |
2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
Armistice Capital, LLC | 6,378,000 8.270% |
-856,898 (-11.84%) |
Filing History |
| 2025-02-14 5:17 pm Sale |
2024-12-31 | 13G | ProMIS Neurosciences, Inc. PMN |
Armistice Capital, LLC | 2,509,977 7.680% |
-160,023 (-5.99%) |
Filing History |
| 2025-02-14 5:17 pm Purchase |
2024-12-31 | 13G | Palisade Bio, Inc. PALI |
Armistice Capital, LLC | 285,417 9.990% |
159,725 (+127.08%) |
Filing History |
| 2025-02-14 5:15 pm Purchase |
2024-12-31 | 13G | Organovo Holdings, Inc. ONVO |
Armistice Capital, LLC | 141,724 9.990% |
20,053 (+16.48%) |
Filing History |
| 2025-02-14 5:15 pm Sale |
2024-12-31 | 13G | Orthofix Medical Inc. OFIX |
Armistice Capital, LLC | 3,000,000 7.850% |
-768,000 (-20.38%) |
Filing History |
| 2025-02-14 5:14 pm Purchase |
2024-12-31 | 13G | Nevro Corp. NVRO |
Armistice Capital, LLC | 3,736,000 9.970% |
8,000 (+0.21%) |
Filing History |
| 2025-02-14 5:13 pm Purchase |
2024-12-31 | 13G | NanoVibronix, Inc. NAOV |
Armistice Capital, LLC | 349,284 9.990% |
42,665 (+13.91%) |
Filing History |
| 2025-02-14 5:11 pm Unchanged |
2024-12-31 | 13G | Mural Oncology plc MURA |
Armistice Capital, LLC | 1,700,000 9.960% |
0 (Unchanged) |
Filing History |
| 2025-02-14 5:08 pm Sale |
2024-12-31 | 13G | Aspira Women's Health Inc. AWH |
Armistice Capital, LLC | 800,797 4.990% |
-455,203 (-36.24%) |
Filing History |
| 2025-02-14 5:08 pm Sale |
2024-12-31 | 13G | Presidio Property Trust, Inc. SQFT |
Armistice Capital, LLC | 756,525 4.990% |
-856,300 (-53.09%) |
Filing History |